Document Detail


Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout mice.
MedLine Citation:
PMID:  20370796     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our previous study found that Chinese yellow wine could inhibit the production of homocysteine (HCY) induced extracellular matrix metalloproteinase-2 (MMP-2) in the cultured rat vascular smooth muscle cells. Little is known about the relationship between Chinese yellow wine and atherosclerosis or MMP-2 in vivo. Thirty-two LDL Receptor knockout mice on a high-fat and L-methionine diet developed plasma hyperhomocysteinemia and atherosclerosis. They were randomly divided into yellow wine group (n = 8), red wine group (n = 8), ethanol group (n = 8), and control group (n = 8), they were sacrificed after 14 weeks. There were no significant differences with plasma total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels in the four groups. Plasma HCY was significantly decreased in the yellow wine group compared to the other three groups (P < 0.01). Yellow wine and red wine groups significantly reduced the atherosclerosis lesion area compared to ethanol and control groups (P < 0.001). However, there was no significant discrepancy between the yellow wine group and red wine group. Compared to the control group and ethanol group, the production of MMP-2 reduced 26.8% and 23.6% in the aortic sinus and the activation of MMP-2 reduced 32.6% and 27.3% in the aortic arch in the yellow wine group; the production of MMP-2 reduced 25.7% and 22.4% in the aortic sinus and the activation of MMP-2 reduced 30.2% and 26.6% in the aortic arch in the red wine group. These results suggest that Chinese yellow wine and red wine can inhibit MMP-2 and improve atherosclerosis, and maybe both Chinese yellow wine and red wine have beneficial effects on cardiovascular disease by inhibiting MMP-2.
Authors:
Hangyuan Guo; Longbin Liu; Yafei Shi; Aijing Sun; Fukang Xu; Jufang Chi; Dilai Huang
Related Documents :
15207376 - Effects of eggplant (solanum melongena) on the atherogenesis and oxidative stress in ld...
19498106 - Vitamin e does not regress hypercholesterolemic atherosclerosis.
16055756 - Lipoprotein retention--and clues for atheroma regression.
19766896 - Rosuvastatin inhibits mmp-2 expression and limits the progression of atherosclerosis in...
7928756 - Influence of dietary lysine on growth and carcass composition of high-lean-growth gilts...
596206 - Difference in sensitivity of parotid glands brought about by disuse and overuse.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-31
Journal Detail:
Title:  Cardiovascular therapeutics     Volume:  28     ISSN:  1755-5922     ISO Abbreviation:  Cardiovasc Ther     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-18     Completed Date:  2010-09-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101319630     Medline TA:  Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  161-8     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Shaoxing People's Hospital, the First Affiliated Hospital of Shaoxing University, Zhejiang, 312000 China. ghangyuan@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alanine Transaminase / blood
Animals
Aortic Diseases / drug therapy*,  enzymology,  genetics,  pathology
Aspartate Aminotransferases / blood
Atherosclerosis / drug therapy*,  enzymology,  genetics,  pathology
Biological Markers / blood
China
Disease Models, Animal
Enzyme Activation
Homocysteine / blood
Lipids / blood
Male
Matrix Metalloproteinase 2 / antagonists & inhibitors*,  metabolism*
Mice
Mice, Inbred C57BL
Mice, Knockout
Protease Inhibitors / pharmacology*
Receptors, LDL / deficiency*,  genetics
Wine*
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Lipids; 0/Protease Inhibitors; 0/Receptors, LDL; 454-28-4/Homocysteine; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.6.1.2/Alanine Transaminase; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.24/Mmp2 protein, mouse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized contro...
Next Document:  High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopat...